Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 183

The DOI matches its Crossref record.

Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?

Gleisner, Ana Luiza, Assumpcao, Lia, Cameron, John L., Wolfgang, Christopher L., Choti, Michael A., Herman, Joseph M., Schulick, Richard D., Pawlik, Timothy M. · 2007 · Cancer

Abstract

BACKGROUND.: To date, no consensus has been reached regarding which primary tumor subtypes are managed appropriately with hepatic metastectomy. Specifically, the role of hepatic resection for metastatic periampullary or pancreatic adenocarcinoma remains controversial. METHODS.: Between 1995 and 2005, 1563 patients underwent surgical resection for periampullary carcinoma (n = 608 patients) or pancreatic adenocarcinoma (head, n = 905 patients; tail, n = 50 patients). Data on demographics, operative details, primary tumor status, and—when indicated—extent of hepatic metastasis were collected. RESULTS.: Of the 1563 patients who underwent resection of periampullary or pancreatic adenocarcinoma, 22 patients (1.4%) underwent simultaneous hepatic resection for synchronous liver metastasis. The primary tumor site was ampullary (n = 1 patient ), duodenal (n = 2 patients), distal bile duct (n = 2 patients), or pancreas (head, n = 10 patients; tail, n = 7 patients). The majority of patients (86.4%) had a solitary hepatic metastasis, and the median size of the largest lesion was 0.6 cm. Hepatic metastectomy included wedge resection (n = 20 patients), segmentectomy (n = 1 patient), and hemihepatectomy (n = 1 patient). After matching patients on primary tumor histology and location, the median survival of patients who underwent hepatic resection of synchronous metastasis was 5.9 months compared with 5.6 months for patients who underwent palliative bypass alone (P = .46) and 14.2 months for patients with no metastatic disease who underwent primary tumor resection only (P < .001). Pancreatic (median, 5.9 months) versus nonpancreatic (median, 9.9 months) primary tumor histology was not associated with a difference in survival in patients who underwent resection of synchronous liver metastasis (P = .43). CONCLUSIONS.: Even in well selected patients with low‐volume metastatic liver disease, simultaneous resection of periampullary or pancreatic carcinoma with synchronous liver metastases did not result in long‐term survival in the overwhelming majority of patients. Cancer 2007. © 2007 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.23074

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 183

Metadata

Authors
Gleisner, A. L., Assumpcao, L., Cameron, J. L., Wolfgang, C. L., Choti, M. A., Herman, J. M., Schulick, R. D., & Pawlik, T. M.
Venue
Cancer
Publisher
Wiley
Published
2007-10-16
Volume
110
Issue
11
Pages
2484-2492
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2017465816
Cited by
183
References
0
FWCI
1.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? https://app.cochat.ai/papers/10.1002/cncr.23074
The paper
Gleisner, A. L., Assumpcao, L., Cameron, J. L., Wolfgang, C. L., Choti, M. A., Herman, J. M., Schulick, R. D., & Pawlik, T. M. (2007). Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? Cancer. https://doi.org/10.1002/cncr.23074

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.